Persistent Right Ventricle Dilatation in SARS-CoV-2-Related Acute Respiratory Distress Syndrome on Extracorporeal Membrane Oxygenation Support체외막 산소 공급에 대한 SARS-CoV-2 관련 급성 호흡 곤란 증후군의 지속적인 우심실 확장Article Published on 2022-07-012022-09-11 Journal: Journal of cardiothoracic and vascular anesthesia [Category] COVID19(2023년), SARS, 치료기술, [키워드] acute respiratory distress acute respiratory distress syndrome acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus 2 ARDS arterial pressure assessment Care changes Clinical management coronavirus coronavirus 2 COVID COVID-related ARDS defined detectable died dilatation disease severity dysfunction echocardiographic echocardiography ECMO exhibited Extracorporeal extracorporeal membrane oxygenation ICU implantation incidence Infection intensive care unit measurement mechanical ventilation membrane Mortality mortality rate nine nonsurvivors Patient patients persistent Prognosis progression reduction in respiratory respiratory distress right right ventricle SARS-CoV-2 SARS-COV-2 infection Severe acute respiratory syndrome severe acute respiratory syndrome Coronavirus severe acute respiratory syndrome coronavirus 2 Support supported Survivors syndrome Treatment tricuspid venovenous extracorporeal membrane oxygenation Ventricle ventricular ventricular dilatation [DOI] 10.1053/j.jvca.2021.08.028 PMC 바로가기 [Article Type] Article
Cardiovascular subphenotypes in patients with COVID-19 pneumonitis whose lungs are mechanically ventilated: a single-centre retrospective observational studyObservational Study Published on 2022-07-012022-10-04 Journal: Anaesthesia [Category] 임상, [키워드] acute respiratory distress acute respiratory distress syndrome age aligned Analysis cardiovascular Clinical characteristics clinical outcomes cohort study conducted echocardiographic ICU patient impairment IQR Latent latent class lung male mechanically ventilated mechanism median moderate mortality rate mortality rates outcomes parameters pathophysiology Patient patients with COVID-19 performed preserved Prone ventilation retrospective right ventricular dysfunction right ventricular failure syndrome transthoracic echocardiography Treatment response Unsupervised clustering variable variables ventricular ventricular dysfunction with COVID-19 [DOI] 10.1111/anae.15700 PMC 바로가기 [Article Type] Observational Study
Sofosbuvir with daclatasvir and the outcomes of patients with COVID-19: a systematic review and meta-analysis with GRADE assessmentdaclatasvir와 Sofosbuvir 및 COVID-19 환자의 결과: GRADE 평가를 통한 체계적인 검토 및 메타 분석Meta-Analysis Published on 2022-07-012022-09-11 Journal: Postgraduate medical journal [Category] 임상, [키워드] Admission certainty of evidence chance clinical clinical pharmacology clinical recovery clinically control group Controlled trial COVID-19 daclatasvir database databases death defined estimate evaluate the effect ICU ICU admission IMV inception increase in Infectious diseases intensive care intensive care unit internal medicine intervention group Invasive mechanical ventilation lower mortality Meta-analysis moderate Mortality mortality rate outcome Patient patients with COVID-19 performed Primary outcome randomised controlled trial reduce mortality rate reduced reported risk ratio risk ratios risk reduction RRs secondary outcome Secondary outcomes sofosbuvir sofosbuvir/daclatasvir Standard of care systematic literature search systematic review Virology [DOI] 10.1136/postgradmedj-2021-140287 PMC 바로가기 [Article Type] Meta-Analysis
A historical cohort study to investigation of statins safety in COVID-19 hospitalized patientsResearch article Published on 2022-07-012022-10-05 Journal: Thérapie [Category] COVID19(2023년), SARS, 신약개발, [키워드] 95% CI addition Admission age anti-inflammatory properties association cardiovascular diseases Chronic kidney disease CKD cohort study condition conditions Corticosteroids COVID COVID-19 COVID-19 infected patients COVID-19 patient COVID19 decrease diabetes evaluated groups hospital Hospitalization hospitalized COVID-19 patients hospitalized patient hypertension ICU ICU admission implementation Inflammatory marker inhibitor intensive care Mortality mortality rate notable Odds ratio outcome proportion Result SARS-CoV-2 severity Sex shown significant difference significantly single-center statin statins statistical analysis Statistics stroke Tehran variable was performed [DOI] 10.1016/j.therap.2021.10.006 [Article Type] Research article
Survival of the hospitalized patients with COVID-19 receiving atorvastatin: A randomized clinical trialRandomized Controlled Trial Published on 2022-07-012022-10-04 Journal: Journal of medical virology [Category] COVID19(2023년), SARS, 임상, [키워드] 95% confidence interval atorvastatin COVID-19 decrease duration of hospitalization Effect evaluate the effect FIVE Frequency greater hazard ratio Hospitalization hospitalized patient Hydroxychloroquine ICU intervention group intubation Kaletra® median Mortality mortality rate occurred outcome Patient patients died Pneumonia Probability progression Pulse rate randomized clinical trial Randomized controlled trial randomly divided receiving Sepsis Seven Standard therapy survival Symptom Treatment was performed with COVID-19 [DOI] 10.1002/jmv.27710 PMC 바로가기 [Article Type] Randomized Controlled Trial
Thromboprophylaxis and clinical outcomes in moderate COVID-19 patients: A comparative studyResearch article Published on 2022-07-012022-10-05 Journal: Research in social & administrative pharmacy : RSA [Category] 임상, [키워드] Anticoagulant Anticoagulants bleeding Care Clinical outcome clinical outcomes complications coronavirus disease COVID-19 discharge dose Efficacy enoxaparin evaluated hospital Hospital stay Hospitalization hypoxia ICU ICU admission in-hospital mortality incidence intensive care involved medication Mild moderate Moderate COVID-19 mortality rate objective outcome Patient patients with moderate Pneumonia Prophylactic Prophylaxis proportion Result rivaroxaban significant difference subcutaneously Thromboprophylaxis thrombotic thrombotic complication Thrombotic events transferred Treatment two groups [DOI] 10.1016/j.sapharm.2022.07.004 [Article Type] Research article
Chemokines, soluble PD-L1, and immune cell hyporesponsiveness are distinct features of SARS-CoV-2 critical illness케모카인, 가용성 PD-L1 및 면역 세포 저반응은 SARS-CoV-2 중병의 뚜렷한 특징입니다Article Published on 2022-07-012022-09-12 Journal: American journal of physiology. Lung cellular and [Category] COVID19(2023년), MERS, SARS, 진단, [키워드] acute respiratory syndrome ARDS C-reactive protein CCL17 CCL26 cellular checkpoint pathway chemoattractant comparison coronavirus disease Coronavirus-2 COVID-19 Critical Critically ill patient CRP CXCL10 demographics enrolled feature hyporesponsiveness identify IFN-γ IL-10 IL-17A IL-6 IL-8 immune Immune cell immune signature in vitro Interaction less lymphocyte Migration molecular monocyte mortality rate multisite not significantly different p value Patient patients patients without COVID-19 PD-L1 plasma Pneumonia profile prospective cohort Regulatory SARS-CoV-2 SARS-CoV-2-positive patient SARS-CoV-2-positive patients Sepsis severe respiratory failure severity subject subjects T cell T-cell TNF-α two groups ventilator-free day with COVID-19 [DOI] 10.1152/ajplung.00049.2022 PMC 바로가기 [Article Type] Article
Human versus Artificial Intelligence–Based Echocardiographic Analysis as a Predictor of Outcomes: An Analysis from the World Alliance Societies of Echocardiography COVID StudyResearch article Published on 2022-07-012022-10-05 Journal: Journal of the American Society of Echocardiograph [Category] 바이오마커, [키워드] acute COVID-19 addition all-cause mortality Alliance Analysis artificial artificial intelligence automated Biomarker Cardiac imaging correlation COVID COVID-19 Direct disease echocardiographic echocardiography Ejection fraction enrolled feasibility Follow-up follow-up period had more hospital Human Hypothesis In-hospital left Left ventricular function LVEF machine learning Mortality mortality rate multivariable Odds ratio Outcomes prediction Patient predict Predictive predictor regression analysis Result significantly Society Statistical power transthoracic echocardiography univariable Variability ventricular WASE with COVID-19 [DOI] 10.1016/j.echo.2022.07.004 [Article Type] Research article
COVID-19 outbreak trends in South Africa: A comparison of Omicron (B.1.1.529), Delta (B.1.617.2), and Beta (B.1.351) variants outbreak periods남아프리카 공화국의 COVID-19 발생 추세: 오미크론(B.1.1.529), 델타(B.1.617.2) 및 베타(B.1.351) 변종 발생 기간 비교Article Published on 2022-07-012022-09-11 Journal: Journal of infection and public health [Category] COVID19(2023년), SARS, 변종, [키워드] addition average B.1.1.529 B.1.351 B.1.617.2 Bayesian information criterion Beta Beta (B.1.351) center correlation COVID-19 COVID-19 case COVID-19 cases COVID-19 outbreak data-driven database death Delta Delta (B.1.617.2) density ellipsoid Engineering fatality growth growth rate incidence Johns Hopkins Johns Hopkins University Joinpoint regression analysis less mortality rate omicron Omicron (B.1.1.529) Omicron variant outbreak Oxford peaked proportion provided Regression model reported Repository Safe Science significant increase significantly South South Africa System University of Oxford variant [DOI] 10.1016/j.jiph.2022.05.011 PMC 바로가기 [Article Type] Article
Outcome of COVID-19 in interstitial lung disease patients treated with anti-inflammatory drugs and antiviral drugs항염증제 및 항바이러스제 치료를 받는 간질성 폐질환 환자의 코로나19 결과Article Published on 2022-07-012022-09-11 Journal: Journal of infection and chemotherapy : official j [Category] 치료제, [키워드] Affect age and sex anti-inflammatory drug antiviral drug antiviral drugs Antiviral treatment coronavirus disease Coronavirus disease 2019 Corticosteroid corticosteroid therapy Corticosteroids COVID-19 COVID-19 patient COVID-19 patients death Diagnosis evaluate Favipiravir fibrosis honeycomb lung HRCT Idiopathic pulmonary fibrosis ILD immunosuppressive agent Immunosuppressive agents increased risk Interstitial lung disease interstitial pneumonia lung Lung disease medical record medical records mortality rate no statistical difference outcome Patient patients treated patients with COVID-19 proportion pulmonary fibrosis Remdesivir reported risk factor Risk factors selected severe disease Severe patient severe patients treated Univariate analysis [DOI] 10.1016/j.jiac.2022.04.006 PMC 바로가기 [Article Type] Article